Georg Halder

Affiliations: 
 
Google:
"Georg Halder"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hillen H, Candi A, Vanderhoydonck B, et al. (2023) A novel irreversible TEAD inhibitor, SWTX-143, blocks Hippo pathway transcriptional output and causes tumor regression in preclinical mesothelioma models. Molecular Cancer Therapeutics
Floc'hlay S, Balaji R, Stanković D, et al. (2023) Shared enhancer gene regulatory networks between wound and oncogenic programs. Elife. 12
Halder G. (2020) Abstract IA07: Hippo signaling in liver regeneration and liver tumors Molecular Cancer Research. 18
Verboven E, Moya IM, Halder G. (2020) Abstract A13: Yap activity in bile ducts, but not in hepatocytes, is required for normal liver regeneration Molecular Cancer Research. 18
Versele M, Candi A, Nijs M, et al. (2020) Abstract 5229: Discovery of novel potent allosteric inhibitors of YAP/TAZ-TEAD transcription for the treatment of multiple solid tumor types addicted to Hippo signaling Cancer Research. 80: 5229-5229
Moya IM, Castaldo SA, Van den Mooter L, et al. (2019) Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice. Science (New York, N.Y.). 366: 1029-1034
Lesaffer B, Verboven E, Van Huffel L, et al. (2019) Comparison of the and Drivers in Bile Ducts of Normal and Injured Mouse Livers. Cells. 8
Moya IM, Halder G. (2018) Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine. Nature Reviews. Molecular Cell Biology
Mach J, Atkins M, Gajewski KM, et al. (2018) Modulation of the Hippo pathway and organ growth by RNA processing proteins. Proceedings of the National Academy of Sciences of the United States of America
Vicente C, Stirparo R, Demeyer S, et al. (2018) The CCR4-NOT complex is a tumor suppressor in Drosophila melanogaster eye cancer models. Journal of Hematology & Oncology. 11: 108
See more...